Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b76c30c1bbba1b914128ccb35683e0b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2103-86 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D319-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-08 |
filingDate |
2017-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8cc4a4ffe27a74cd2d1e9442f724286 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90a722c0d98ecbeba3f6672d55b6fe01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcb8b5142a826efb689dee89fdafcd32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd6afbd18f0991b21bf2de347632cc1d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d4064d2213a49464f041112abd5f5ef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_935b6c0690b55d6014f1f3ae4594ff7a |
publicationDate |
2018-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2018085344-A1 |
titleOfInvention |
Method of use of diterpenoid derivatives as anticancer agents |
abstract |
The present invention relates to a group of derivatives synthesized based on the ent-kaurane diterpenoid flexicaulin A and the methods to synthesize such diterpenoid derivatives. In particular, the chemical entities of such synthetic diterpene compounds in the manufacture of a medicament is for the treatment of tumors or cancers. |
priorityDate |
2016-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |